Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 13 drugs
No. | DrugBank | 薬物名(臨床試験情報から抽出) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Baclofen | 2件: BACLOFEN BACLOFEN; Kemstro | 1件: Baclofen
Baclofen
💬1. Baclofen
| 2件: GABBR1 GABBR1,GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive l ... | 8件: 2 2, 10, 13, 18, 65, 70, 149, 206 💬1. Baclofen
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Botulinum toxin type A | 8件: BOTOX BOTOX; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin 8件: BOTOX; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; Onabotuli ... | 1件: Botulinum toxin type A
Botulinum toxin type A
💬2. Botulinum toxin type A
| 1件: SNAP25 SNAP25 💬2. Botulinum toxin type A
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 14件: 2 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬2. Botulinum toxin type A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Brivaracetam | 1件: BRIVARACETAM BRIVARACETAM | 1件: Brivaracetam
Brivaracetam
💬3. Brivaracetam
| 1件: SV2A SV2A 💬3. Brivaracetam
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 2件: 149 149, 309 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Edonerpic | 1件: Edonerpic Edonerpic | - | - | - | 1件: 149 149 💬4. Edonerpic
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Fenfluramine | 2件: Fenfluramina Fenfluramina; Fenfluramine | 1件: Fenfluramine
Fenfluramine
💬5. Fenfluramine
| 5件: HTR1D HTR1D,HTR2A, HTR2C, SIGMAR1, SLC6A4 💬 | 10件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator r ... | 4件: 140 140, 144, 145, 149 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Flunarizine | 0件: | 1件: Flunarizine
Flunarizine
💬6. Flunarizine
| 3件: CACNA1G CACNA1G,CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 8件: Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol ... | 1件: 149 149 💬6. Flunarizine
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | gamma-Hydroxybutyric acid | 1件: Oxybate Oxybate | - | - | - | 2件: 6 6, 149 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Isoxaflutole | 1件: Balance Balance | - | - | - | 5件: 6 6, 11, 46, 81, 149 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Lacosamide | 1件: Lacosamide Lacosamide | 1件: Lacosamide
Lacosamide
💬9. Lacosamide
| 2件: SCN3A SCN3A,SCN9A 💬 | 1件: Taste transduction Taste transduction 💬 | 4件: 2 2, 46, 149, 298 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Nitrous oxide | 2件: MEOPA MEOPA; Nitrous Oxide | 1件: Nitrous oxide
Nitrous oxide
💬10. Nitrous oxide
| - | - | 2件: 34 34, 149 💬
|